Key Points XRP could grow a lot during the coming years. It will be competing in real-world asset tokenization, money transfers, payment processing, and more. Getting financial institutions onboard is the most important priority for it to succeed. 10 stocks we like better than XRP › Every investor has had the dream of buying a small stake in a compelling asset with perfect timing and vision, and then suddenly seeing a huge return that makes retirement look closer than your next vacation. With XRP ...

Prediction market Polymarket is set to reopen to U.S. users, nearly four years after being effectively banned by the CFTC, and could do so as soon as tomorrow, regulatory filings show. Polymarket, which operates a cryptocurrency-based prediction market on the Polygon network, has begun self-certifying its own event contracts, flexing its authority to do so through the CFTC-licensed exchange it acquired in July. Polymarket acquired QCX LLC, which is now doing business as Polymarket US, for $112 million. By ...

Core Insights - GROW Capital, Inc. has engaged Cherry Bekaert LLP for independent audits of its fiscal 2024 and 2023 financial results, marking a commitment to transparency and regulatory compliance [2][3] - The return to independent audits is seen as a pivotal step towards uplisting to a more senior tier of OTCMarkets and completing a review of a Form 211 under SEC Rule 15c2-11 [3][4] - The company aims to achieve OTCQB tier compliance and explore uplisting opportunities with NASDAQ, NYSE American Exchange, or the upcoming Texas Stock Exchange [4][5] Company Strategy - GROW Capital's strategic goals include scaling subsidiaries, expanding fintech capabilities, and pursuing new market opportunities [5][6] - The company operates through subsidiaries such as PERA LLC, PERA Administrators LLC, and Bombshell Technologies LLC, providing retirement plan administration and fintech solutions [6]

Group 1 - M&T Bank Corporation (MTB) is recognized as one of the 11 Cheap Quarterly Dividend Stocks to buy currently [1] - The company operates as a regional lender with a strong presence in community, commercial, and retail banking, offering services such as mortgage lending and consumer finance [2] - Recent priorities for MTB include regulatory compliance, disciplined capital and liquidity management, risk oversight, and growing fee-based income [3] Group 2 - M&T Bank declared an 11% increase in its quarterly dividend to $1.50 per share, marking the ninth consecutive year of dividend growth [4] - As of September 23, the stock has a dividend yield of 2.99% [4]

Key Takeaways UBS will pay $862.7 million in fines and $124.1 million in damages to settle the French tax case.The dispute stemmed from cross-border business activities between 2004 and 2012.The settlement follows years of appeals and reduced penalties from earlier rulings UBS Group AG (UBS) has agreed to pay €835 million ($986.8 million) to resolve a long-running French tax case concerning its cross-border business activities between 2004 and 2012.On Sept. 23, 2025, the bank announced that it would pay a € ...

FE fundinfo has purchased AlphaOmega, a Luxembourg firm that provides regulatory reporting services for investment managers. As per the terms of the deal, Antoine Capone from AlphaOmega will take up the role of general manager, Luxembourg, and join FE fundinfo’s leadership to assist with product work and client services across Luxembourg and other European markets. AlphaOmega offers regulatory output services for the EU, UK and Switzerland, consolidating reporting processes and applying regulatory tech ...

This story was originally published on C-Store Dive. To receive daily news and insights, subscribe to our free daily C-Store Dive newsletter. Dive Brief: 7-Eleven will pay $1.2 million to resolve charges that it violated a Washington, D.C., restriction on where vapes and e-cigarettes can be sold, the Office of the Attorney General for the District of Columbia announced on Tuesday. A D.C. law enacted in October 2022 prohibits such devices from being sold within a quarter mile of middle and high schools ...

Summary of ICU Medical Conference Call Company Overview - **Company**: ICU Medical - **Industry**: Medical Devices, specifically focusing on infusion systems and consumables Key Points Business Segments Performance - **Consumables Segment**: - Grew 4% in Q2, with expectations of mid-single digit growth for the year [4] - Historical growth rate of 5-6% annually over the past five years [4] - Drivers include strong end-market demand, demographic trends, and a national shortage of IV solutions [4][5] - Incremental innovations and FDA clearances are expected to enhance competitive advantage [6][8] - **IV Systems**: - Double-digit growth in LVP (Large Volume Pump) revenue [10] - Market growth is estimated at 3-4%, with ICU Medical outpacing this due to market refresh from competitors' device issues [12] - Focus on integrating various pumping modalities into a single software platform for improved user experience [10][11] - **Vital Care Division**: - Approximately $600 million division, now reduced to $300 million post joint venture with Otsuka Pharmaceutical [24][25] - Experienced a decline of 4% in Q2, with expectations of flat growth moving forward [29] Regulatory Landscape - Regulatory scrutiny is high, which is seen as a necessary barrier to ensure safety in drug delivery systems [15] - The company is focused on maintaining compliance and improving product standards to avoid setbacks [45] Innovation and Product Development - Recent FDA approvals for new products are expected to drive growth in both consumables and IV systems [16][17] - The company is investing in R&D to enhance product offerings and maintain competitive edge [42] Financial Guidance and Market Outlook - Updated guidance reflects a $17 million EBITDA loss from divestiture and $30 million in tariffs impacting the second half of the year [35][36] - Anticipated growth in 2026 is supported by innovation in consumables and a potential increase in average selling prices (ASP) for new pump technologies [40][46] - The company aims for mid-single digit growth while improving gross margins and generating cash flow for shareholder returns [42][57] Strategic Focus - Emphasis on home care as a growth area, leveraging existing market share and technology [22][20] - The company is cautious about pursuing new M&A opportunities unless they are compelling [57] Competitive Landscape - ICU Medical is positioned well against competitors by offering integrated solutions that enhance user experience and operational efficiency [18][19] - The company is focused on differentiating its offerings in the home care market, which is fragmented and competitive [21] Conclusion - ICU Medical is at a pivotal point with ongoing innovations and strategic initiatives aimed at sustaining growth and enhancing shareholder value. The focus remains on executing current opportunities while navigating regulatory challenges and market dynamics [61]

RT Wendy O (@CryptoWendyO)The Wyoming Stable Token Commission announced that the Frontier Stable Token (FRNT), the first U.S. state-issued stable token, will soon be available on Hedera.FRNT is fully backed by U.S. dollars and short-term Treasuries, supporting faster, more transparent, and efficient payments.Interest earned from Treasury purchases will fund Wyoming’s School Foundation Program, benefiting education across the state.Hedera was chosen for its speed, low costs, and strong regulatory compliance. ...

Financial Performance - Company reported revenue of $4.6 million for the third quarter of fiscal 2025, a decrease of 10.9% from $5.2 million in the same period last year [2][12] - Operating loss increased to $0.9 million from $0.4 million in the prior year [2][12] - Year-to-date revenues decreased slightly from $14.9 million to $14.5 million [12] Strategic Developments - Major overhaul of the marketing team and digital strategy has been completed to address the revenue decline [3] - The beverage brand, Oasis, has expanded distribution to 7 states, with e-commerce growth accelerating since July [3][7] - Company is actively engaging with industry associations and legislators to navigate regulatory changes impacting wholesale partners [3][4] Regulatory Environment - Recent positive developments at the national level include progress on the farm bill and cannabis scheduling discussions from the White House [4] - Increased regulatory scrutiny is expected to favor compliant brands and may drive industry consolidation, presenting opportunities for the company [4] Financial Position - As of June 30, 2025, the company had working capital of approximately $2.0 million and cash on hand of approximately $1.1 million, an improvement from a working capital deficit of $2.2 million the previous year [12] - The book value of equity increased significantly from $0.67 million to approximately $6.1 million following the conversion of Series A Preferred Stock [7] Sales Breakdown - Direct-to-consumer (DTC) net sales accounted for 78% of total net sales in the third quarter, totaling $3.6 million, compared to $3.9 million or 76% in the prior year [12] - Wholesale net sales were $1.0 million, representing 22% of total net sales, down from $1.2 million in the same quarter last year [12]